Allogene Therapeutics (NASDAQ:ALLO) Target Lowered by JMP Securities to $27.00

StockMarketDaily.co reports: stock has undergone multiple analysts rating changes in the recent past.  stock Target Lowered by   JMP Securities on 10/12/2021. In a note to investors, the firm issued a new target price of $27.00. The analysts previously had $53.00 target price.

View More Allogene Therapeutics (NASDAQ:ALLO) Target Lowered by JMP Securities to $27.00

Confused? Buy or Sell in volatile market – Analyst report Allogene Therapeutics (NASDAQ:ALLO)

Earnings results for Allogene Therapeutics , Analyst Opinion on Allogene Therapeutics , Earnings and Valuation of (NASDAQ:ALLO), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Confused? Buy or Sell in volatile market – Analyst report Allogene Therapeutics (NASDAQ:ALLO)

Is it time to Buy before this week’s earning report Allogene Therapeutics (NASDAQ:ALLO)

Earnings results for Allogene Therapeutics , Analyst Opinion on Allogene Therapeutics , Earnings and Valuation of (NASDAQ:ALLO), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Is it time to Buy before this week’s earning report Allogene Therapeutics (NASDAQ:ALLO)

How Have the Numbers Shaped Up for Allogene Therapeutics (NASDAQ:ALLO)

Earnings results for Allogene Therapeutics , Analyst Opinion on Allogene Therapeutics , Earnings and Valuation of (NASDAQ:ALLO), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More How Have the Numbers Shaped Up for Allogene Therapeutics (NASDAQ:ALLO)

Earnings results might Drive Its Stock Price Allogene Therapeutics (NASDAQ:ALLO)

Earnings results for Allogene Therapeutics , Analyst Opinion on Allogene Therapeutics , Earnings and Valuation of (NASDAQ:ALLO), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Earnings results might Drive Its Stock Price Allogene Therapeutics (NASDAQ:ALLO)